ANI Pharma (ANIP) Tops Q3 EPS by 1c

November 3, 2016 9:35 AM EDT
Get Alerts ANIP Hot Sheet
Trade ANIP Now!
Join SI Premium – FREE

Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here.

ANI Pharma (NASDAQ: ANIP) reported Q3 EPS of $1.09, $0.01 better than the analyst estimate of $1.08. Revenue for the quarter came in at $38.5 million versus the consensus estimate of $34.34 million.

GUIDANCE:

ANI Pharma sees FY2016 EPS of $4.00-$4.25, versus the consensus of $4.09. ANI Pharma sees FY2016 revenue of $128-134 million, versus the consensus of $126.1 million.

For earnings history and earnings-related data on ANI Pharma (ANIP) click here.



Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In






Related Categories

Earnings, Guidance

Related Entities

Earnings

Add Your Comment